Lack of Hypoglycemic Symptoms and Decreasedβ-Adrenergic Sensitivity in Insulin-Dependent Diabetic Patients
- 1 February 1988
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 66 (2) , 273-278
- https://doi.org/10.1210/jcem-66-2-273
Abstract
Plasma epinephrine, norepinephrine, and dopamine responses were studied in insulin-dependent diabetic patients at rest, on standing and during insulin-induced hypoglycemia. β-Adrenergic sensitivity was evaluated by the isoproterenol sensitivity test. Five men who had adrenergic symptoms during hypoglycemia and no severe hypoglycemic accidents (coma, seizures) (group A) and five men who had repeated severe hypoglycemic accidents but lack of adrenergic symptoms of hypoglycemia (group B) were studied. The mean resting plasma epinephrine was lower in group B (147 ± 22 pmol/L, sem) than in group A (398 ± 98 pmol/L, P < 0.02). On standing plasma epinephrine increased significantly in both groups. During hypoglycemia blood glucose decreased identically in the two groups; plasma epinephrine and norepinephrine increased significantly and to the same extent in both groups; the mean maximal heart rate was significantly greater in group A than in group B. Isoproterenol sensitivity (defined as the dose of isoproterenol required to increase heart rate by 25 beats/min) was lower in group B (5.87 ± 1.12 μg) than in group A (2.37 ± 0.22 μg, P < 0.01). The group B patients had significantly fewer hypoglycemic symptoms during insulin-induced hypoglycemia than did group A patients. We conclude that decreased β-adrenergic sensitivity contributes to the lack of adrenergic symptoms of hypoglycemia in insulin-dependent diabetic patients.Keywords
This publication has 16 references indexed in Scilit:
- Intensive Insulin Therapy Reduces Counterregulatory Hormone Responses to Hypoglycemia in Patients with Type I DiabetesAnnals of Internal Medicine, 1985
- Glucoregulation during insulin and glucagon deficiency: role of catecholaminesAmerican Journal of Physiology-Endocrinology and Metabolism, 1982
- Reduced Epinephrine Secretion and Hypoglycemia Unawareness in Diabetic Autonomic NeuropathyAnnals of Internal Medicine, 1982
- Role of Epinephrine-mediated β-Adrenergic Mechanisms in Hypoglycemic Glucose Counterregulation and Posthypoglycemic Hyperglycemia in Insulin-dependent Diabetes MellitusJournal of Clinical Investigation, 1982
- Altered Responsiveness to Cortisol, Epinephrine, and Glucagon in Insulin-infused Juvenile-onset Diabetics: A Mechanism for Diabetic InstabilityDiabetes, 1980
- Impaired Responses of Catecholamines, Growth Hormone, and Cortisol to Graded Exercise in Diabetic Autonomic NeuropathyDiabetes, 1980
- Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in ManJournal of Clinical Investigation, 1980
- Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose CounterregulationJournal of Clinical Investigation, 1979
- Hyporeninemic Hypoaldosteronism in Diabetes Mellitus: Studies of the Autonomic Nervous System's Control of Renin ReleaseDiabetes, 1979
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977